Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.47 |
| ▸ | P2RX3 | P56373 | 5/20 | 0.40 |
| ▸ | P2RX4 | Q99571 | 4/20 | 0.40 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.40 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.36 |
| ▸ | ENTPD1 | P49961 | 1/20 | 0.35 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143054 | 0.85 | POLRMT (0.49) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL22355496 | 0.82 | POLRMT (0.46) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL10141879 | 0.81 | POLRMT (0.47) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL21343890 | 0.81 | POLRMT (0.52) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL20878409 | 0.79 | POLRMT (0.50) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL23047623 | 0.78 | POLRMT (0.50) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL24058168 | 0.77 | POLRMT (0.48) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL4967938 | 0.77 | POLRMT (0.48) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL23047655 | 0.77 | POLRMT (0.49) | POLRMTP2RX3P2RX4P2RX1P2RX2 | |
| SCHEMBL19504899 | 0.76 | POLRMT (0.47) | POLRMTP2RX3P2RX4P2RX1P2RX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021243157-A1 | REMDESIVIR TREATMENT METHODS | GILEAD SCIENCES, INC. (US) | 2021-12-02 | — | — | WO | disclosed |